Here Are the Facts You Need to Understand Agilent Technologies (A)

Shares of Large-cap industrials company Agilent Technologies moved -0.1 this afternoon, and are now trading at $112.25 per share. On the other hand, the average analyst target price for the stock is $139.13.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Potential Agilent Technologies Investors Should Analyze the Following:

  • Agilent Technologies has moved -11.0% over the last year.

  • The company has a price to earnings growth (PEG) ratio of 2.61. A number between 0 and 1 could mean that the market is undervaluing Agilent Technologies's estimated growth potential

  • Its Price to Book (P/B) ratio is 5.91

  • Agilent Technologies currently returns an annual dividend yield of 0.8%.

Understanding Agilent Technologies's Operating Margins

Date Reported Total Revenue ($ k) Operating Expenses ($ k) Operating Margins (%) YoY Growth (%)
2022-12-21 6,848,000 -2,104,000 24 14.29
2021-12-17 6,319,000 -2,060,000 21 31.25
2020-12-18 5,339,000 -1,991,000 16 -11.11
2019-12-19 5,163,000 -1,864,000 18 0.0
2018-12-20 4,914,000 -1,776,000 18 -5.26
2017-12-21 4,472,000 -1,568,000 19

Agilent Technologies's operating margins have averaged 19.3% over the last 6 years, which is significantly higher than the Biotechnology industry average of 15.02%. The firm's margins exhibit a relatively stable growth trend of 3.7%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.